WallStSmart

Keurig Dr Pepper Inc (KDP)vsArcadia Biosciences Inc (RKDA)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Keurig Dr Pepper Inc generates 423204% more annual revenue ($20.09B vs $4.75M). KDP leads profitability with a 7.1% profit margin vs -234.5%. KDP earns a higher WallStSmart Score of 61/100 (C+).

KDP

Buy

61

out of 100

Grade: C+

Growth: 6.0Profit: 5.0Value: 6.7Quality: 4.0
Piotroski: 5/9Altman Z: 1.09

RKDA

Hold

36

out of 100

Grade: F

Growth: 4.0Profit: 2.0Value: 6.0Quality: 5.3
Piotroski: 3/9Altman Z: -58.76
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

KDPUndervalued (+63.1%)

Margin of Safety

+63.1%

Fair Value

$81.12

Current Price

$31.39

$49.73 discount

UndervaluedFair: $81.12Overvalued
RKDAUndervalued (+24.4%)

Margin of Safety

+24.4%

Fair Value

$2.30

Current Price

$0.43

$1.87 discount

UndervaluedFair: $2.30Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

KDP2 strengths · Avg: 9.0/10
Revenue GrowthGrowth
75.6%10/10

Revenue surging 75.6% year-over-year

Price/BookValuation
1.7x8/10

Reasonable price relative to book value

RKDA2 strengths · Avg: 9.0/10
Price/BookValuation
1.5x10/10

Reasonable price relative to book value

EPS GrowthGrowth
28.5%8/10

Earnings expanding 28.5% YoY

Areas to Watch

KDP4 concerns · Avg: 3.3/10
P/E RatioValuation
32.9x4/10

Premium valuation, high expectations priced in

Return on EquityProfitability
5.7%3/10

ROE of 5.7% — below average capital efficiency

Profit MarginProfitability
7.1%3/10

7.1% margin — thin

Debt/EquityHealth
1.373/10

Elevated debt levels

RKDA4 concerns · Avg: 2.5/10
Market CapQuality
$1.14M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Return on EquityProfitability
-323.1%2/10

ROE of -323.1% — below average capital efficiency

Revenue GrowthGrowth
-0.8%2/10

Revenue declined 0.8%

Comparative Analysis Report

WallStSmart Research

Bull Case : KDP

The strongest argument for KDP centers on Revenue Growth, Price/Book. Revenue growth of 75.6% demonstrates continued momentum. PEG of 1.01 suggests the stock is reasonably priced for its growth.

Bull Case : RKDA

The strongest argument for RKDA centers on Price/Book, EPS Growth.

Bear Case : KDP

The primary concerns for KDP are P/E Ratio, Return on Equity, Profit Margin.

Bear Case : RKDA

The primary concerns for RKDA are Market Cap, Piotroski F-Score, Return on Equity.

Key Dynamics to Monitor

KDP profiles as a hypergrowth stock while RKDA is a turnaround play — different risk/reward profiles.

RKDA carries more volatility with a beta of 0.53 — expect wider price swings.

KDP is growing revenue faster at 75.6% — sustainability is the question.

KDP generates stronger free cash flow (714M), providing more financial flexibility.

Bottom Line

KDP scores higher overall (61/100 vs 36/100) and 75.6% revenue growth. RKDA offers better value entry with a 24.4% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Keurig Dr Pepper Inc

CONSUMER DEFENSIVE · BEVERAGES - NON-ALCOHOLIC · USA

Keurig Dr Pepper Inc. is a beverage company in the United States and internationally. The company is headquartered in Burlington, Massachusetts.

Arcadia Biosciences Inc

CONSUMER DEFENSIVE · PACKAGED FOODS · USA

Arcadia Biosciences, Inc. is dedicated to developing various crop productivity traits primarily in hemp, wheat, and soybeans. The company is headquartered in Davis, California.

Visit Website →

Want to dig deeper into these stocks?